Bioprocessors Might Grapple With Contaminants, Media...
More than 20,000 microRNA-Focused Publications Were...
Biopharma Giants Posting more Positions; Alexion...
Upstream’s Relatively Continuous Flows Raise Hopes...
Since President Barack Obama enacted a law intended to spark business growth by encouraging “crowdfunding” of startups a year ago, new sites have sprung up employing different crowdfunding models toward raising money for biopharmas and researchers. (You can learn about two of them, Poliwogg and Microryza, here.) Have you jumped on the crowdfunding bandwagon?
Do you think regulatory agencies should be required to provide stronger evidence of the clinical effectiveness of cancer drugs, including a greater emphasis on patient survival time?
Be sure to add email@example.com
to your Address Book or Safe Senders List.
here for instructions.
If you have any questions about your subscription, click
here to email us or call at (914) 740-2189.
You may also be interested in subscribing to the GEN magazine, an indispensable
resource for everyone involved in the business of translating discoveries at the
bench into solutions that fight disease and improve health, agriculture, and the
today to see why over 60,000 biotech professionals read GEN to
keep current in the areas of genomics, proteomics, drug discovery, biomarker discovery,
bioprocessing, molecular diagnostics, collaborations, biotech business trends, and
© 2015 Genetic Engineering & Biotechnology News All Rights Reserved